← FDA Drug Approvals (Drugs@FDA)

XELJANZ XR

NDA · New Drug Application · Sponsor: PFIZER · Approved 2016-02-23

Drug application

FDA Application #

NDA208246

Application type

New Drug Application

Brand name

XELJANZ XR

Generic name

TOFACITINIB

Active ingredients

TOFACITINIB CITRATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

PFIZER

Manufacturer

Pfizer Laboratories Div Pfizer Inc

First approval

2016-02-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown